Results 91 to 100 of about 239,701 (294)

Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register‐based study 2000–2015

International Journal of Cancer, EarlyView.
What's New? This study shows that absolute and relative educational inequalities in cervical cancer mortality are much larger in the Baltic countries than in Finland, where an organized screening programme was introduced more than 40 years earlier. After the introduction of organized screening, cervical cancer mortality declined among low‐educated ...
Oskar Nõmm, Kaire Innos, Domantas Jasilionis, Juris Krumins, Pekka Martikainen, Kersti Pärna, Andrew Stickley, Mall Leinsalu   +7 more
wiley   +1 more source

Prospects for controlling cervical cancer at the turn of the century

Salud Pública de México, 2003
Cervical cancer morbidity and mortality have decreased substantially during the last 50 years mostly due to success-ful organized or opportunistic screening with Pap cytology in high and middle income countries.
Franco Eduardo L, Duarte-Franco Eliane, Ferenczy Alex   +2 more
doaj  

The Cellular Bromodomain Protein Brd4 has Multiple Functions in E2-Mediated Papillomavirus Transcription Activation

Viruses, 2014
The cellular bromodomain protein Brd4 functions in multiple processes of the papillomavirus life cycle, including viral replication, genome maintenance, and gene transcription through its interaction with the viral protein, E2. However, the mechanisms by
Christine M. Helfer, Junpeng Yan, Jianxin You   +2 more
doaj   +1 more source

Papillomavirus E6 oncoproteins

Virology, 2013
Papillomaviruses induce benign and malignant epithelial tumors, and the viral E6 oncoprotein is essential for full transformation. E6 contributes to transformation by associating with cellular proteins, docking on specific acidic LXXLL peptide motifs found on these proteins.
Vande Pol, Scott B., Klingelhutz, Aloysius J.   +1 more
openaire   +2 more sources

Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2‐dependent manner

International Journal of Cancer, EarlyView.
What's New? Hypoxic regions and inflammatory Th17 cells in the tumor environment are both associated with poor prognosis in cervical cancer. However, synergistic mechanisms between hypoxia and Th17 cells remain elusive. This study demonstrated Th17–hypoxia‐driven mechanisms underlying cervical cancer progression.
Selina Gies, Maike Pohlers, Tanja Tänzer, Emmanuel Ampofo, Matthias W. Laschke, Moritz Schäfer, Yoo‐Jin Kim, Rainer Maria Bohle, Erich‐Franz Solomayer, Konrad Wagner, Martin Empting, Alexandra K. Kiemer, Barbara Walch‐Rückheim   +12 more
wiley   +1 more source

Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile

Infectious Agents and Cancer, 2011
Background Human papillomavirus (HPV) and Epstein Barr virus (EBV) have been found in breast carcinomas (BCs) around the world. In this study, fifty-five BCs from Chile were analyzed for HPV and EBV presence.
Eizuru Yoshito, Solís Luisa, Padilla Oslando, Ampuero Sandra, González Carolina, Koriyama Chihaya, Khan Noureen, Aguayo Francisco, Corvalán Alejandro, Akiba Suminori   +9 more
doaj   +1 more source

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, EarlyView.
What's New? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

SAMHD1 Regulates Human Papillomavirus 16-Induced Cell Proliferation and Viral Replication during Differentiation of Keratinocytes

mSphere, 2019
Human papillomaviruses induce a host of anogenital cancers, as well as oropharyngeal cancer (HPV+OPC); human papillomavirus 16 (HPV16) is causative in around 90% of HPV+OPC cases.
Claire D. James, Apurva T. Prabhakar, Raymonde Otoa, Michael R. Evans, Xu Wang, Molly L. Bristol, Kun Zhang, Renfeng Li, Iain M. Morgan   +8 more
doaj   +1 more source

Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland [PDF]

, 2013
<p>Background: A vaccination programme targeted against human papillomavirus (HPV) types16 and 18 was introduced in the UK in 2008, with the aim of decreasing incidence of cervical disease.
A Das, A Szarewski, Alasdair I MacDonald, AS Licht, CBJ Woodman, CD Walsh, CE Schmeink, Christine Campbell, D Metcalfe, F Samkange-Zeeb, GP Lloyd, Graham Lough, H zur Hausen, HL Bowyer, Ishbel Macqueen, JA Tiro, K Cuschieri, K Trim, K Williams, L Bell, LAV Marlow, LAV Marlow, M Mosavel, M Pitts, MA Stanley, N Ghotbi, N Munoz, P Juntasopeepun, R Caskey, S Blödt, S Hilton, Sarah M McCusker, SC Cooper Robbins, Sheila V Graham, SJ Klug   +34 more
core   +2 more sources

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms

International Journal of Cancer, EarlyView.
What's New? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll, Jesper Bonde, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Merete Nielsen, Bettina Kjær Kristensen, Doris Schledermann, Berit Andersen, on behalf ofthe National Danish Cervical Cancer Screening Steering Committee   +11 more
wiley   +1 more source